Overcoming Challenges of Drug Development in Behavioural Variant Frontotemporal Dementia

February 26, 2021
Henry J. Riordan, PhD | Natalia Drosopoulou, PhD | Tom Babic, MD, PhD
Your form has been successfully submitted! Click the button below to access.
VIEW PDF
Henry J. Riordan, PhD
MEET THE AUTHOR

Henry J. Riordan, PhD

Chief Development Officer
LEARN MORE
Natalia Drosopoulou, PhD
MEET THE AUTHOR

Natalia Drosopoulou, PhD

Vice President, Project Management, Psychiatry, Alzheimer’s Disease and other Dementias
LEARN MORE
Tom Babic, MD, PhD
MEET THE AUTHOR

Tom Babic, MD, PhD

Vice President, Scientific Solutions, Neuroscience
LEARN MORE